Emami Ltd logo

Emami Ltd

EMAMILTD NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹17,866 Cr
Volatility
Moderate
P/E Ratio
24.06
EBITDA
₹1,049 Cr
Return on Equity
26.53%
Debt to Equity
0.06
Book Value
₹66.99
EPS
₹17.04
52W High
₹634.2
52W Low
₹376.4

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Emami Ltd insights

66 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

4
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 28.5%
  • Company has been maintaining a healthy dividend payout of 52.9%
  • Debtor days have improved from 42.3 to 33.2 days.

Weaknesses

2
  • The company has delivered a poor sales growth of 5.58% over past five years.
  • Tax rate seems low

Growth Rate

Revenue Growth
-0.33% ↘
Net Income Growth
-3.41% ↘
Cash Flow Change
-10.64% ↘
ROE
-10.97% ↘
ROCE
-12.81% ↘
EBITDA Margin (Avg.)
-3.76% ↘

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 3d ago
AI opinion · based on fundamentals
Risk medium

Emami Ltd is a nearly debt-free FMCG company with a market cap of ₹17,449 Cr trading at a PE of 22.8x. The company delivers strong return on equity (3-year ROE of 28%) and maintains a healthy dividend payout of 52.9%, but has struggled with tepid sales growth of just 5% CAGR over 10 years and a declining stock price that has fallen 34% over the past year.

Bull Case 7
  • Company is almost debt-free, providing significant financial flexibility and low interest burden
  • Strong 3-year ROE of 28.5% and 5-year ROE of 31%, indicating efficient capital allocation
  • Healthy dividend payout ratio of 52.9% with a current dividend yield of 2.55%, rewarding shareholders consistently
  • Debtor days improved from 42.3 to 33.2 days, reflecting better working capital management
  • Compounded profit growth of 11% over 5 years outpaces sales growth, suggesting margin expansion and operating leverage
  • PE ratio of 22.8x is reasonable for an FMCG company with near-zero debt and high ROE, compared to sector averages
  • 10-year compounded profit growth of 6% against 5% sales growth shows consistent ability to grow bottom line faster than top line
Bear Case 8
  • Stock price has declined 34% over the past 1 year, significantly underperforming broader markets
  • Poor compounded sales growth of just 4% over 3 years and 6% over 5 years, indicating limited top-line momentum
  • TTM profit growth is negative at -7%, showing recent earnings deterioration
  • Stock CAGR is negative across all timeframes: -4% over 3 years, -7% over 5 years, and -3% over 10 years, reflecting sustained value destruction for shareholders
  • TTM sales growth of only 3% barely keeps pace with inflation, suggesting volume stagnation
  • Price-to-book ratio of 5.86x is elevated for a company delivering only 3% TTM revenue growth
  • Tax rate appears low, which if normalized could compress reported earnings further
  • 10-year sales CAGR of only 5% suggests structural challenges in scaling the brand portfolio

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 1d ago
Headwinds 2
  • Q1 PAT down 16% YoY Aug 4

    Net profit fell 16% YoY to ₹137 crore in Q1FY27 due to higher input costs and increased tax expenses, with effective tax rate at 25-26% after fiscal benefits ended.

  • Auditor qualified conclusion Aug 4

    Statutory auditors issued a qualified conclusion on Q1FY26 results due to unreviewed subsidiary financials following acquisitions of Axiom Ayurveda and IncNut Digital.

Positives 4
  • Revenue up 15% on domestic strength Aug 4

    Consolidated revenue rose 15% to ₹1,039 crore in Q1FY27 driven by strong domestic growth, with strategic portfolio posting 61% growth deemed sustainable for the rest of the year.

  • Kesh King targets double-digit growth Aug 5

    Management expects Kesh King to reach double-digit growth by year-end despite mid-single-digit Q1 performance, with pricing adjustments expected to offset rising input costs and support steady margins.

  • 10.5% emission reduction in FY26 Jul 30

    Emami achieved a 10.5% reduction in Scope 1 and Scope 2 emissions for FY26, reaching plastic neutrality and 90% sustainable packaging — strengthening ESG credentials.

  • Promoters release pledged shares Jul 11

    Promoters Diwakar Finvest and Suraj Finvest released shares pledged with Bajaj Finance and Indusind Bank on July 10, 2026, reducing promoter pledge overhang.

Neutral 3
  • 43rd AGM scheduled Aug 25 Jul 27

    Emami's 43rd AGM is scheduled for August 25, 2026 via video conferencing, with e-voting available August 20-24 and integrated annual report dispatched.

  • ₹21.15 Cr block trade on NSE Jul 21

    Approximately 5.24 lakh shares traded in a single block deal at ₹403.55 per share on NSE, totaling ₹21.15 crore, suggesting institutional-level participation.

  • Q1FY27 earnings call held Aug 4 Jul 15

    Emami hosted an investor conference call on August 4, 2026 featuring Vice Chairman and CEO to discuss Q1FY27 unaudited financial results.

TL;DR: Emami delivered solid 15% revenue growth in Q1FY27 led by domestic business and a 61% jump in its strategic portfolio, but profitability took a hit with PAT declining 16% on higher input costs and tax burden. Management is guiding for margin recovery through pricing actions and expects Kesh King and international business to accelerate in H2. Key risks are sustained cost inflation and integration of recent acquisitions. The trend is cautiously improving if pricing-led margin recovery materializes as guided.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
826
865
996
891
906
891
1,049
963
904
799
1,152
925
1,039
Expenses
636
632
682
682
692
645
715
744
692
622
768
739
815
Operating Profit
190
233
314
209
214
246
334
219
212
177
384
186
225
OPM %
23%
27%
32%
24%
24%
28%
32%
23%
23%
22%
33%
20%
22%
Other Income
8
11
11
11
10
22
15
21
22
21
9
23
18
Interest
2
2
3
3
2
2
2
3
2
3
3
3
6
Depreciation
46
46
46
48
44
45
46
44
44
45
45
42
43
PBT
150
196
276
169
178
220
301
194
187
150
345
164
195
Tax %
9%
8%
6%
13%
16%
4%
7%
16%
12%
1%
7%
13%
29%
Net Profit
137
180
261
147
151
211
279
162
164
148
319
143
139
EPS in Rs
3.14
4.09
5.92
3.41
3.5
4.87
6.39
3.72
3.76
3.4
7.32
3.28
3.15
Figures in ₹ Crores

Profit & Loss

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
2,076
2,358
2,488
2,531
2,695
2,655
2,881
3,192
3,406
3,578
3,809
3,780
3,915
Expenses
1,536
1,670
1,729
1,812
1,970
1,970
2,000
2,254
2,550
2,632
2,796
2,820
2,943
Operating Profit
541
688
759
719
725
685
880
938
855
946
1,014
960
972
OPM %
26%
29%
31%
28%
27%
26%
31%
29%
25%
26%
27%
25%
25%
Other Income
91
44
31
19
25
46
69
90
69
41
68
75
72
Interest
5
54
58
34
21
21
13
5
7
10
9
11
14
Depreciation
34
255
309
311
325
336
367
335
247
186
178
177
176
PBT
592
423
424
393
403
374
569
688
670
791
894
846
854
Tax %
18%
14%
20%
22%
25%
19%
20%
-22%
6%
8%
10%
8%
—
Net Profit
485
363
340
306
303
302
455
837
627
724
803
775
750
EPS in Rs
10.7
8
7.5
6.77
6.68
6.67
10.23
19.02
14.5
16.58
18.48
17.76
17.15
Div. Payout %
33%
44%
47%
52%
60%
60%
78%
42%
55%
48%
54%
56%
—
Figures in ₹ Crores

Balance Sheet

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
23
23
23
23
45
45
44
44
44
44
44
44
Reserves
1,208
1,589
1,732
1,991
2,031
1,778
1,718
2,032
2,259
2,403
2,651
2,880
Borrowings
36
671
473
326
110
210
101
282
91
94
90
162
Other Liabilities
410
409
376
458
633
644
656
692
703
728
741
745
Total Liabilities
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Fixed Assets
453
1,918
1,994
1,802
1,680
1,459
1,132
1,344
1,245
1,114
984
886
CWIP
29
67
22
30
36
8
6
3
6
8
15
1
Investments
501
104
128
314
187
156
255
303
293
442
676
834
Other Assets
693
604
460
652
915
1,055
1,126
1,400
1,551
1,706
1,850
2,108
Total Assets
1,676
2,692
2,603
2,798
2,819
2,678
2,520
3,050
3,096
3,269
3,525
3,831
Figures in ₹ Crores

Cash Flow

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
534
562
730
588
554
531
922
644
749
779
896
801
Investing
-237
-1,313
-306
-276
-26
-231
-224
-234
-122
-210
-345
-174
Financing
-215
502
-496
-324
-428
-405
-688
-402
-608
-563
-500
-554
Net Cash Flow
82
-249
-72
-12
100
-106
9
8
19
6
52
72
Free Cash Flow
426
430
448
465
421
383
890
164
719
750
852
770
CFO/OP
116
96
105
93
89
89
115
84
101
98
107
101
Figures in ₹ Crores

Ratios

  Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
18
20
14
22
29
42
29
37
44
50
43
33
Inventory Days
59
68
83
87
88
102
118
121
100
102
94
128
Days Payable
90
112
85
109
115
135
138
138
124
143
133
153
Cash Conversion Cycle
-13
-24
12
1
2
9
10
19
20
9
4
8
Working Capital Days
-16
-54
-62
-32
-6
7
-3
0
28
30
25
21
ROCE %
61%
30%
23%
22%
19%
18%
29%
31%
28%
32%
32%
28%

Shareholding Pattern

As of Jun 2026
Promoters 54.84%
DIIs 27.01%
FIIs 7.87%
Public 5.76%
Others 4.51%
Total 99.99%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
53.86%
53.86%
53.86%
53.86%
54.27%
54.27%
54.27%
54.27%
54.27%
54.52%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
54.84%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
13.46%
14.02%
14.38%
14.11%
12.11%
11.89%
10.93%
9.03%
8.58%
7.87%
DIIs
23.09%
22.23%
23.65%
25.42%
24.28%
26.45%
26.99%
27.02%
26.92%
26.20%
25.22%
23.77%
22.07%
21.61%
21.51%
21.70%
23.67%
24.06%
25.01%
26.73%
26.92%
27.01%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
4.60%
4.34%
4.18%
4.03%
4.00%
3.93%
3.75%
3.86%
4.05%
3.60%
3.90%
4.01%
4.74%
4.84%
4.93%
5.40%
5.38%
5.30%
5.26%
5.37%
5.62%
5.76%
Others
18.46%
19.57%
18.32%
16.70%
17.45%
15.35%
14.99%
14.85%
14.76%
15.68%
16.05%
17.38%
4.89%
4.69%
4.34%
3.95%
4.00%
3.89%
3.95%
4.03%
4.04%
4.51%
No. of Shareholders
0
82,090
81,508
82,193
83,257
86,242
89,971
85,460
90,285
89,955
79,216
82,151
91,334
97,258
1,27,897
1,28,725
1,29,002
1,26,599
1,26,776
1,29,077
1,27,615
1,31,617

Documents

Frequently Asked Questions about Emami Ltd

What does Emami Ltd do?
Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)
Where is Emami Ltd (EMAMILTD) listed?
Emami Ltd is listed on the Indian stock exchanges. It is listed on NSE: EMAMILTD and BSE: 531162. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Emami Ltd belong to?
Emami Ltd operates in the Consumer Goods sector within the Personal Care industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Emami Ltd?
Emami Ltd has a market capitalisation of approximately ₹17865.94 Cr. Based on this, it is classified as a Mid Cap stock.
What is the PE ratio of Emami Ltd?
The Price-to-Earnings (PE) ratio of Emami Ltd is 24.06. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Emami Ltd?
Over the past 52 weeks, Emami Ltd has traded between a low of ₹376.4 and a high of ₹634.2. This range helps investors understand the stock's price volatility and recent trading levels.
Does Emami Ltd pay dividends?
Yes, Emami Ltd has a dividend yield of 2.44%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Emami Ltd?
Emami Ltd has a Return on Equity (ROE) of 26.53%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Emami Ltd on Tapetide?
On Tapetide, you can view Emami Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Emami is engaged in manufacturing & marketing of personal care & healthcare products with an enviable portfolio of household brand names such as BoroPlus, Navratna, Fair and Handsome, Zandu Balm, Kesh King, Zandu Pancharishta, Mentho Plus Balm and others.(Source : 201903 Annual Report Page No: 193)

Website emamiltd.in
CEO Mr. Radhe Shyam Goenka B.Com., L.L.B., M.Com. LLB
Employees 3,217
Listed 2006-08-03
Face Value ₹ 1
Issued Size 43,65,00,000

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List